Literature DB >> 2825191

Epstein-Barr virus genomes in lymphoid cells: activation in mitosis and chromosomal location.

C G Teo1, B E Griffin.   

Abstract

Biotin-labeled Epstein-Barr virus (EBV)-specific DNA probes have been used to detect viral genomes by in situ hybridization. Immunocytochemically amplified signals produced by the hybridized probe allow visualization of viral DNA even in cells previously reported to contain only one or two EBV genomes. In EBV producer lymphoid cell lines, such as B95-8, P3HR-1, or Daudi, activation of latent EBV DNA could be observed in mitotic cells; in non-virus-producing cells of these same lines, EBV was found to be present in low copy numbers. Noninducible cell lines such as IB4, AW-Ramos, and Namalwa exhibited low but clearly positive hybridization. Unexpectedly, significant variations in the amounts of EBV DNA per cell were observed between individual cells of these lines. The EBV DNA in the cloned IB4 cell line was localized to chromosome 4 in metaphase cells, but in the noncloned converted line AW-Ramos, the location of integrated viral DNA was essentially random.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2825191      PMCID: PMC299566          DOI: 10.1073/pnas.84.23.8473

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Detection of viral sequences of low reiteration frequency by in situ hybridization.

Authors:  M Brahic; A T Haase
Journal:  Proc Natl Acad Sci U S A       Date:  1978-12       Impact factor: 11.205

2.  Amounts of Epstein-Barr virus DNA in somatic cell hybrids between burkitt lymphoma-derived cell lines.

Authors:  M Andersson
Journal:  J Virol       Date:  1975-11       Impact factor: 5.103

Review 3.  Biotin-labeled DNA probes for detection of Epstein-Barr virus by in-situ cytohybridization.

Authors:  J W Sixbey; J S Pagano
Journal:  Clin Lab Med       Date:  1985-09       Impact factor: 1.935

4.  Integrated viral DNA sequences in Epstein-Barr virus-converted human lymphoma lines.

Authors:  M Andersson-Anvret; T Lindahl
Journal:  J Virol       Date:  1978-03       Impact factor: 5.103

5.  Epstein-Barr virus DNA in human lymphoid cell lines: in vitro conversion.

Authors:  M Andersson; T Lindahl
Journal:  Virology       Date:  1976-08       Impact factor: 3.616

6.  An EBV-genome-negative cell line established from an American Burkitt lymphoma; receptor characteristics. EBV infectibility and permanent conversion into EBV-positive sublines by in vitro infection.

Authors:  G Klein; B Giovanella; A Westman; J S Stehlin; D Mumford
Journal:  Intervirology       Date:  1975       Impact factor: 1.763

7.  Cleavage of Epstein-Barr virus DNA by restriction endonucleases EcoRI, HindIII and BamI.

Authors:  L Rymo; S Forsblom
Journal:  Nucleic Acids Res       Date:  1978-04       Impact factor: 16.971

8.  Detection of Epstein-Barr virus (EBV) DNA sequences using in situ hybridization.

Authors:  M H Moar; G Klein
Journal:  Biochim Biophys Acta       Date:  1978-06-22

9.  Homology between Epstein-Barr virus DNA and viral DNA from Burkitt's lymphoma and nasopharyngeal carcinoma determined by DNA-DNA reassociation kinetics.

Authors:  M Nonoyama; J S Pagano
Journal:  Nature       Date:  1973-03-02       Impact factor: 49.962

10.  Differential inducibility of Epstein-Barr virus in cloned, non-producer Raji cells.

Authors:  K Bister; N Yamamoto; H zur Hausen
Journal:  Int J Cancer       Date:  1979-06-15       Impact factor: 7.396

View more
  10 in total

1.  Detection of Epstein-Barr virus by in situ hybridization. Progress toward development of a nonisotopic diagnostic test.

Authors:  R Bashir; F Hochberg; R H Singer
Journal:  Am J Pathol       Date:  1989-12       Impact factor: 4.307

2.  Detection of single copies of Epstein-Barr virus in paraffin wax sections by non-radioactive in situ hybridisation.

Authors:  P J Coates; W P Mak; G Slavin; A J d'Ardenne
Journal:  J Clin Pathol       Date:  1991-06       Impact factor: 3.411

3.  Detection and chromosomal assignment of SV40-DNA integration in Chinese hamster cell lines by chromosome sorting and dot blot hybridization.

Authors:  K J Hutter; H Klefenz; K Goerttler
Journal:  Histochemistry       Date:  1990

4.  Persistence of Epstein-Barr virus in salivary gland biopsies from healthy individuals and patients with Sjögren's syndrome.

Authors:  P J Venables; C G Teo; C Baboonian; B E Griffin; R A Hughes
Journal:  Clin Exp Immunol       Date:  1989-03       Impact factor: 4.330

5.  In situ demonstration of Epstein-Barr viral genomes in viral-associated B cell lymphoproliferations.

Authors:  L M Weiss; L A Movahed
Journal:  Am J Pathol       Date:  1989-03       Impact factor: 4.307

6.  Identification of the Epstein-Barr virus terminal protein gene products in latently infected lymphocytes.

Authors:  D T Rowe; L Hall; I Joab; G Laux
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

7.  Negative modulation of Epstein-Barr virus episomes by a human B-cell growth factor.

Authors:  J Morgan; A Roome; A Maizel; S Sharma
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

8.  The systemic distribution of Epstein-Barr virus genomes in fatal post-transplantation lymphoproliferative disorders. An in situ hybridization study.

Authors:  P S Randhawa; R Jaffe; A J Demetris; M Nalesnik; T E Starzl; Y Y Chen; L M Weiss
Journal:  Am J Pathol       Date:  1991-04       Impact factor: 4.307

9.  Chromosomal location of endogenous geminivirus-related DNA sequences in Nicotiana tabacum L.

Authors:  A Kenton; A Khashoggi; A Parokonny; M D Bennett; C Lichtenstein
Journal:  Chromosome Res       Date:  1995-09       Impact factor: 5.239

10.  Development of a non-invasive method, multiplex methylation specific PCR (MMSP), for early diagnosis of nasopharyngeal carcinoma.

Authors:  Zhe Zhang; Di Sun; Susanna Hilda Hutajulu; Imran Nawaz; Do Nguyen Van; Guangwu Huang; Sofia M Haryana; Jaap M Middeldorp; Ingemar Ernberg; Li-Fu Hu
Journal:  PLoS One       Date:  2012-11-05       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.